The Role of E-cadherin N-glycans in Oral Cancer

E-钙粘蛋白 N-聚糖在口腔癌中的作用

基本信息

  • 批准号:
    7420929
  • 负责人:
  • 金额:
    $ 28.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Oral cancer constitutes 1 of the most pernicious cancers with only a 5-year predicted survival following diagnosis. Our research proposes to elucidate some of the underlying causes of oral cancer by focusing on the nature of cell-cell contacts in human oral cancer cells. The long-term goal of our studies is to determine the role of N-glycosylation in the formation of E-cadherin-mediated cell-cell contacts in oral cancer cells. E-cadherin, with its documented role as a tumor suppressor, is the principal cell-cell adhesion receptor in oral epithelial cells. Although changes in N-glycan structures have long been known to be corollaries of tumor formation and metastasis, no information is available about how these structures affect E-cadherin adhesive function. E-cadherin ectodomains, which function in the formation of homotypic cell-cell contacts, have several potential N-glycan addition sites, while the cytosolic tail binds catenins that provide the linkage to the actin cytoskeleton. We have shown that during cell proliferation and migration, E-cadherin is extensively N-glycosylated and present in unstable cell-cell contacts. In contrast, in cytodifferentiated cells, E-cadherin is scarcely N-glycosylated and found in stable junctional complexes associated with the actin cytoskeleton. Our initial studies in vivo and ex vivo show that inappropriate increase in E-cadherin N-glycosylation in differentiated salivary cells reverses E-cadherin-mediated cell-cell contacts from stable to weak. Importantly, many cancer cells have highly N-glycosylated E-cadherin that is present in weak cell-cell contacts. Our hypothesis is that the N-glycosylation status of E- cadherin regulates its tumor suppressive function. We propose to test this hypothesis in 4 specific aims: 1) to demonstrate that highly N-glycosylated E-cadherin is a characteristic of oral cancer cell lines; 2) to show that high levels of E-cadherin N-glycosylation drive the formation of unstable E-cadherin-mediated cell-cell contacts; 3) to determine the signaling events through which N-glycosylation status of E-cadherin affects oral cancer cell proliferation and survival; and 4) to show that N-glycosylation status of E-cadherin regulates its tumor suppressive activity in SCID mice in vivo. Our proposed studies will increase the understanding of the basis of E-cadherin tumor suppressive activity in oral cancer and will serve as a basis for the development of novel treatment strategies.
描述(由申请人提供):口腔癌是最致命的癌症之一,诊断后预测生存期仅为5年。我们的研究旨在通过关注人类口腔癌细胞中细胞-细胞接触的性质来阐明口腔癌的一些根本原因。我们研究的长期目标是确定N-糖基化在口腔癌细胞中E-钙粘蛋白介导的细胞-细胞接触形成中的作用。E-钙粘蛋白是口腔上皮细胞中主要的细胞间粘附受体,具有肿瘤抑制作用。虽然N-聚糖结构的变化早已被认为是肿瘤形成和转移的必然结果,但没有关于这些结构如何影响E-钙粘蛋白粘附功能的信息。E-钙粘蛋白胞外域在形成同型细胞与细胞接触中发挥作用,具有几个潜在的N-聚糖添加位点,而胞质尾部结合连环蛋白,提供与肌动蛋白细胞骨架的连接。我们已经表明,在细胞增殖和迁移,E-钙粘蛋白是广泛的N-糖基化,并存在于不稳定的细胞-细胞接触。相反,在细胞分化的细胞中,E-钙粘蛋白几乎没有N-糖基化,并在与肌动蛋白细胞骨架相关的稳定连接复合物中发现。我们的初步研究在体内和离体显示,不适当的增加在分化的唾液细胞的E-钙粘蛋白N-糖基化逆转E-钙粘蛋白介导的细胞-细胞接触从稳定到弱。重要的是,许多癌细胞具有存在于弱细胞-细胞接触中的高度N-糖基化的E-钙粘蛋白。我们的假设是E-钙粘蛋白的N-糖基化状态调节其肿瘤抑制功能。我们拟从4个方面验证这一假说:1)证明高度N-糖基化的E-cadherin是口腔癌细胞系的特征; 2)证明高水平的E-cadherin N-糖基化驱动不稳定的E-cadherin介导的细胞-细胞接触的形成; 3)确定E-cadherin N-糖基化状态影响口腔癌细胞增殖和存活的信号事件;和4)显示E-钙粘蛋白的N-糖基化状态调节其在SCID小鼠体内的肿瘤抑制活性。我们提出的研究将增加对E-钙粘蛋白在口腔癌中肿瘤抑制活性的基础的理解,并将作为开发新的治疗策略的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARIA A. KUKURUZINSKA其他文献

MARIA A. KUKURUZINSKA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARIA A. KUKURUZINSKA', 18)}}的其他基金

Enhancement and Cloud Deployment of CaDrA, a software tool for Candidate Driver Analysis of Multiomics Data
CaDrA 的增强和云部署,这是一种用于多组学数据候选驱动程序分析的软件工具
  • 批准号:
    10406590
  • 财政年份:
    2021
  • 资助金额:
    $ 28.71万
  • 项目类别:
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer
定义头颈癌中的 β-连环蛋白/CBP-连环蛋白/CBP 轴
  • 批准号:
    10312814
  • 财政年份:
    2020
  • 资助金额:
    $ 28.71万
  • 项目类别:
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer
定义头颈癌中的 β-连环蛋白/CBP-连环蛋白/CBP 轴
  • 批准号:
    10521284
  • 财政年份:
    2020
  • 资助金额:
    $ 28.71万
  • 项目类别:
Repair, Regeneration and Fibrosis of the Salivary Gland
唾液腺的修复、再生和纤维化
  • 批准号:
    9098687
  • 财政年份:
    2015
  • 资助金额:
    $ 28.71万
  • 项目类别:
2013 Salivary Glands and Exocrine Biology Gordon Research Conference
2013年唾液腺和外分泌生物学戈登研究会议
  • 批准号:
    8524089
  • 财政年份:
    2013
  • 资助金额:
    $ 28.71万
  • 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
  • 批准号:
    8170891
  • 财政年份:
    2010
  • 资助金额:
    $ 28.71万
  • 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
  • 批准号:
    7955918
  • 财政年份:
    2009
  • 资助金额:
    $ 28.71万
  • 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
  • 批准号:
    7723006
  • 财政年份:
    2008
  • 资助金额:
    $ 28.71万
  • 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
  • 批准号:
    7602000
  • 财政年份:
    2007
  • 资助金额:
    $ 28.71万
  • 项目类别:
The Role of E-cadherin N-glycans in Oral Cancer
E-钙粘蛋白 N-聚糖在口腔癌中的作用
  • 批准号:
    7873024
  • 财政年份:
    2006
  • 资助金额:
    $ 28.71万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.71万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.71万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.71万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 28.71万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 28.71万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 28.71万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 28.71万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 28.71万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 28.71万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 28.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了